United Therapeutics shareholders approve 2026 Stock Incentive Plan with 1.5M new shares

UNITED THERAPEUTICS Corp

Plan adds 1,500,000 new shares; total reserve includes 2,413,730 carryover from prior plan plus returning shares.
Shareholders approved plan with 25,872,075 for, 10,070,290 against (72% support); advisory say-on-pay also passed.
All 12 director nominees elected; highest vote total was Kevin Tracey with 36,187,554 for, lowest was Christopher Causey with 32,342,983.
Plan allows options, SARs, restricted stock, RSUs, stock awards, and incentive bonuses; administered by Compensation Committee.
Effective June 26, 2026; no further grants under the 2015 plan; prior awards unaffected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.